CBS19 reports on research suggesting app-based support and structured meal plans may help people hold their weight after coming off GLP-1 drugs.
Recap by typeshit. Full story at cbs19.tv.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Christina DiArcangelo points out that GLP-1 drugs now come in different versions for weight loss and metabolic health, and argues they shouldn't be treated as interchangeable.
Tino Bourse points to new Wegovy data showing a large cut in liver fat in patients with obesity, plus continued oral version results, as possible good news for Novo stock.
Loading…